My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Board of Rallis India recommends final dividend
Apr 25,2017

Rallis India announced that the Board of Directors of the Company at its meeting held on 24 April 2017, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 250%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Tata Metaliks recommends final dividend
Apr 25,2017

Tata Metaliks announced that the Board of Directors of the Company at its meeting held on 21 April 2017, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Wendt India to hold AGM
Apr 25,2017

Wendt India announced that the Annual General Meeting (AGM) of the company will be held on 24 July 2017.

Powered by Capital Market - Live News

Board of Reliance Industries recommends final dividend
Apr 25,2017

Reliance Industries announced that the Board of Directors of the Company at its meeting held on 24 April 2017, inter alia, have recommended the final dividend of Rs 11 per equity Share (i.e. 110%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Wendt India recommends final dividend
Apr 25,2017

Wendt India announced that the Board of Directors of the Company at its meeting held on 24 April 2017, inter alia, have recommended the final dividend of Rs 15 per equity Share (i.e. 150%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hydrochlorothiazide Tablets
Apr 25,2017

Alembic Pharmaceuticals has received USFDA final approval for Olmesartan Medoxomil Tablets, 5mg, 20mg and 40mg and Olmesartan Medoxomil with Hydrochlorothiazide Tablets 20/12.5 mg, 40/12.5 mg and 40/25 mg. The approved ANDAs are indicated for the treatment of hypertension.

Powered by Capital Market - Live News

Jubilant Life Sciences receives final approval for Olmesartan Medoxomil Tablets
Apr 25,2017

Jubilant Life Sciences has received from USFDA Abbreviated New Drug Application final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension.

Powered by Capital Market - Live News

Tribhovandas Bhimji Zaveri to relaunch its renovated Vijayawada showroom
Apr 25,2017

Tribhovandas Bhimji Zaveri announced that the Company is relaunching in grand new renovated Vijaywada showroom with large range of Diamond and Gold Collection on Tuesday, 25 April 2017.

Powered by Capital Market - Live News

Pincon Spirit enters into bottling tie-up
Apr 25,2017

Pincon Spirit has undergone a bottling tie-up with Nethravathi Distilleries situated at Bangalore Mangalore Road, Avargere Village, Kunigal Taluk, Kunigal, Karnataka for supply and distribution of goods in the state of Kerala.

Powered by Capital Market - Live News

BHEL provides update on its largest ever Rs 10000 crore export order
Apr 25,2017

Bharat Heavy Electricals (BHELs) largest ever export order, valued at Rs 10,000 crore (USD 1.5 billion) for setting up 1320 MW (2x660 MW) Maitree Super Thermal Power Project in Bangladesh, has taken off, following the issuance of the Notice To Proceed by the developer.

The order has been secured from Bangladesh India Friendship Power Company, a 50:50 JV Company of NTPC, India and BPDB, Bangladesh.

Powered by Capital Market - Live News

DCB Bank opens QIP issue
Apr 25,2017

DCB Bank announced that the Capital Raising Committee of the Bank (the Committee) in its meeting held on 24 April 2017 which concluded at 07:05 p.m. has, inter alia, passed the following resolutions:

a. Approving the preliminary placement document dated 24 April 2017 in connection with the QIP;

b. Authorising the opening of the QIP on 24 April 2017; and

c. Approval of the floor price for the QIP.

The Relevant Date for this purpose, in terms of Regulation 81(c)(i) of the SEBI ICDR Regulations, is 24 April 2017 and accordingly the floor price in respect of the aforesaid QIP, based on the pricing formula as prescribed under Regulation 85(1) of the SEBI ICDR Regulations is ` 177.39 per Equity Share. Pursuant to Regulation 85 of the SEBI ICDR Regulations the Bank may offer a discount of not more than 5% on the floor price so calculated for the QIP.

Powered by Capital Market - Live News

Quick Heal Technologies allots 19505 equity shares
Apr 25,2017

Quick Heal Technologies has made allotment of 19505 Equity Shares under ESOP on 24 April 2017. The total issued share capital after this allotment stands at 700,90,505 equity shares of Rs 10 each.

Powered by Capital Market - Live News

Axis Bank allots 5,74,405 equity shares
Apr 25,2017

Axis Bank has allotted 5,74,405 equity shares of Rs. 2/- each on 24 April 2017, pursuant to exercise of options under its ESOP Scheme. The paid up share capital of the Bank will accordingly increase from Rs. 479,15,43,818 (239,57,71,909 equity shares of Rs. 2/- each) to Rs. 479,26,92,628 (239,63,46,314 equity shares of Rs. 2/- each).

Powered by Capital Market - Live News

Karnataka Bank appoints company secretary and compliance officer
Apr 25,2017

Karnataka Bank appoints Prasanna Patil as Company Secretary and Compliance Officer of the Bank as per SEBI (LODR) Regulations,2015 w.e.f. 24 April 2017

Powered by Capital Market - Live News

Infosys opens delivery center in Karlovac, Croatia
Apr 25,2017

Infosys announced it is strengthening its engineering footprint in Eastern Europe by opening its first office and delivery center(DC) in Karlovac, Croatia.

The Karlovac facility in Croatia is the latest location across 16 regions in Europe which Infosys has opened as part of its ongoing commitment to client servicing and local job creation.

Powered by Capital Market - Live News